Pregnancy, breastfeeding, allergies, certain medical conditions, medications, active illness, fever, or previous reactions may affect candidacy
Many clinicians hail GLP-1- and GIP/GLP-1-based therapies as breakthroughs. The Economist went so far as to say that the new classes of drugs could end obesity globally
As the newest GLP-1 agonist, Mounjaro works in the same way as Ozempic/Wegovy and Saxenda but has an additional action that maximises insulin sensitivity, potential leading to added weight loss benefits
Liquid drops or concentrates absorb quickly but are best suited for home use, as the lids can loosen and leak in a pack
One key change was adding a fatty acid molecule, which helps the drug to be released slowly
You are responsible for understanding and complying with all import/export regulations and customs requirements